CN Stock MarketDetailed Quotes

002550 Changzhou Qianhong Biopharma

Watchlist
  • 5.66
  • -0.01-0.18%
Not Open Aug 13 15:00 CST
7.24BMarket Cap36.28P/E (TTM)

Changzhou Qianhong Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-24.19%461.1M
-21.24%1.81B
-11.09%1.47B
-7.05%1.06B
10.14%608.22M
22.86%2.3B
20.50%1.65B
30.23%1.14B
41.16%552.22M
12.43%1.87B
Operating revenue
-24.19%461.1M
-21.24%1.81B
-11.09%1.47B
-7.05%1.06B
10.14%608.22M
22.86%2.3B
20.50%1.65B
30.23%1.14B
41.16%552.22M
12.43%1.87B
Other operating revenue
----
358.99%5.17M
----
126.10%3.34M
----
10.02%1.13M
----
189.36%1.48M
----
91.28%1.02M
Total operating cost
-33.42%344.36M
-16.33%1.67B
-6.59%1.3B
-0.81%936.63M
14.65%517.22M
15.25%1.99B
15.53%1.39B
23.42%944.29M
41.68%451.12M
17.50%1.73B
Operating cost
-41.52%216.07M
-27.23%1.03B
-16.26%836.54M
-12.52%614.97M
12.42%369.5M
35.85%1.41B
32.94%998.98M
43.29%702.99M
51.55%328.68M
19.20%1.04B
Operating tax surcharges
14.28%6.39M
19.31%20.4M
16.11%15.08M
-3.29%8.82M
-7.30%5.59M
-6.79%17.1M
2.14%12.99M
29.64%9.12M
141.96%6.03M
-8.08%18.35M
Operating expense
-11.21%78.39M
-6.62%393.86M
-8.93%308.74M
6.76%217.34M
13.64%88.29M
-8.99%421.76M
4.65%339M
5.48%203.58M
4.46%77.69M
25.97%463.44M
Administration expense
0.20%26.16M
6.55%131.76M
14.78%93.67M
21.71%62.82M
9.08%26.11M
-3.32%123.66M
-2.78%81.61M
-6.47%51.61M
5.88%23.94M
7.46%127.91M
Financial expense
-101.84%-131.26K
91.38%-6.39M
92.35%-6.74M
84.38%-8.33M
101.43%7.15M
-1,429.75%-74.2M
-703.53%-88.14M
-556.05%-53.33M
137.44%3.55M
-73.17%5.58M
-Interest expense (Financial expense)
-55.98%726.67K
13.22%5.93M
34.73%5.54M
34.62%3.91M
-12.51%1.65M
215.73%5.23M
192.62%4.11M
278.29%2.9M
408.28%1.89M
-80.37%1.66M
-Interest Income (Financial expense)
50.95%-2.02M
-100.25%-11.3M
-105.66%-8.19M
-156.67%-6.18M
-428.96%-4.12M
-252.63%-5.64M
-4.70%-3.98M
-17.20%-2.41M
35.14%-777.97K
73.40%-1.6M
Research and development
-15.12%17.48M
9.93%97.08M
11.20%53.17M
35.26%41M
83.32%20.59M
24.06%88.31M
8.59%47.81M
10.59%30.31M
-2.54%11.23M
2.95%71.18M
Credit Impairment Loss
-173.91%-6.06M
215.42%17.43M
250.15%16.64M
164.11%8.45M
190.02%8.21M
-128.80%-15.1M
-121.44%-11.08M
-1,241.54%-13.19M
-166.58%-9.11M
113.70%52.43M
Asset Impairment Loss
----
-3,685.29%-19.62M
---1.39K
---1.39K
---1.39K
4.27%-518.22K
----
--0
--0
86.44%-541.35K
Adjustment items of total operating cost
----
----
----
----
---0.01
----
----
----
----
----
Other net revenue
-97.67%262.25K
17.75%56.13M
320.08%28.86M
186.84%14.56M
254.18%11.24M
-23.31%47.67M
-124.54%-13.11M
-5,077.46%-16.76M
-69.42%-7.29M
117.18%62.17M
Fair value change income
158.63%430.73K
670.53%771.38K
122.09%440.84K
-10.05%323.9K
-63.32%166.55K
-89.88%100.11K
8.78%198.5K
135.87%360.09K
599.76%454.06K
123.63%988.86K
Invest income
972.47%3.03M
270.72%8M
143.66%3.65M
112.33%945.07K
127.73%282.36K
-1,244.58%-4.69M
-19.26%-8.35M
4.60%-7.67M
84.45%-1.02M
-102.24%-348.72K
Asset deal income
----
-55.98%25.35M
--208.74
----
----
--57.59M
----
----
----
--0
Other revenue
10.95%2.87M
135.25%24.2M
32.99%8.14M
29.65%4.84M
8.15%2.59M
6.76%10.28M
-28.62%6.12M
-47.21%3.73M
-57.31%2.39M
9.77%9.63M
Operating profit
14.45%117.01M
-43.24%204.36M
-20.18%194.34M
-23.40%134.68M
8.97%102.23M
71.97%360.01M
12.35%243.46M
62.45%175.83M
36.94%93.82M
227.06%209.34M
Add:Non operating Income
-98.63%1.83K
-52.01%350.92K
-56.69%25.5M
-99.76%141.92K
-99.77%133.89K
79.92%731.23K
14,884.84%58.89M
18,480.51%58.58M
18,518.53%58.14M
749.97%406.43K
Less:Non operating expense
1,636.66%174.4K
190.70%1.18M
174.83%1.07M
-78.49%65.2K
-93.47%10.04K
10.96%407.28K
15.18%388.05K
32.25%303.18K
20.14%153.74K
-91.67%367.03K
Total profit
14.15%116.83M
-43.52%203.52M
-27.55%218.78M
-42.44%134.76M
-32.57%102.36M
72.10%360.33M
39.31%301.96M
116.13%234.11M
120.99%151.8M
223.81%209.38M
Less:Income tax cost
-17.64%15.49M
-38.52%24.85M
-30.47%31.12M
-45.03%21.09M
-27.69%18.81M
75.47%40.42M
36.61%44.76M
65.62%38.36M
82.74%26.01M
207.18%23.04M
Net profit
21.30%101.35M
-44.15%178.67M
-27.04%187.65M
-41.93%113.67M
-33.58%83.55M
71.68%319.91M
39.79%257.2M
129.87%195.75M
130.98%125.8M
FLtoP186.34M
Net profit from continuing operation
21.30%101.35M
-44.15%178.67M
-27.04%187.65M
-41.93%113.67M
-33.58%83.55M
71.68%319.91M
39.79%257.2M
129.87%195.75M
130.98%125.8M
226.23%186.34M
Less:Minority Profit
-15.20%-2.76M
8.99%-3.19M
8.91%-10.2M
12.35%-5.36M
2.22%-2.4M
-166.56%-3.5M
-88.67%-11.2M
-53.03%-6.11M
-2,507.97%-2.45M
133.73%5.26M
Net profit of parent company owners
21.13%104.11M
-43.77%181.86M
-26.28%197.86M
-41.03%119.03M
-32.98%85.95M
78.60%323.41M
41.32%268.4M
126.42%201.86M
135.93%128.25M
237.16%181.08M
Earning per share
Basic earning per share
23.07%0.0827
-44.00%0.14
-27.68%0.1549
-42.35%0.0931
-34.50%0.0672
66.67%0.25
40.74%0.2142
125.87%0.1615
135.32%0.1026
236.36%0.15
Diluted earning per share
23.07%0.0827
-44.00%0.14
-27.68%0.1549
-42.35%0.0931
-34.50%0.0672
66.67%0.25
40.74%0.2142
125.87%0.1615
135.32%0.1026
236.36%0.15
Other composite income
-2,850.69%-1.32M
118.33%420.5K
56.43%-1.57M
-159.64%-409.7K
-106.87%-44.83K
-173.72%-2.29M
-14,922.82%-3.59M
4,878.38%687K
2,266.05%652.35K
450.79%3.11M
Other composite income of parent company owners
-2,850.69%-1.32M
118.33%420.5K
56.43%-1.57M
-159.64%-409.7K
-106.87%-44.83K
-173.72%-2.29M
-14,922.82%-3.59M
4,878.38%687K
2,266.05%652.35K
450.79%3.11M
Total composite income
19.78%100.02M
-43.61%179.09M
-26.62%186.09M
-42.34%113.26M
-33.96%83.51M
67.65%317.62M
37.86%253.61M
130.71%196.43M
132.06%126.45M
227.57%189.46M
Total composite income of parent company owners
19.65%102.79M
-43.24%182.28M
-25.87%196.29M
-41.44%118.62M
-33.36%85.9M
74.34%321.12M
39.45%264.81M
127.23%202.54M
137.01%128.9M
238.59%184.19M
Total composite income of minority owners
-15.20%-2.76M
8.99%-3.19M
8.91%-10.2M
12.35%-5.36M
2.22%-2.4M
-166.56%-3.5M
-88.67%-11.2M
-53.03%-6.11M
-2,507.97%-2.45M
133.73%5.26M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -24.19%461.1M-21.24%1.81B-11.09%1.47B-7.05%1.06B10.14%608.22M22.86%2.3B20.50%1.65B30.23%1.14B41.16%552.22M12.43%1.87B
Operating revenue -24.19%461.1M-21.24%1.81B-11.09%1.47B-7.05%1.06B10.14%608.22M22.86%2.3B20.50%1.65B30.23%1.14B41.16%552.22M12.43%1.87B
Other operating revenue ----358.99%5.17M----126.10%3.34M----10.02%1.13M----189.36%1.48M----91.28%1.02M
Total operating cost -33.42%344.36M-16.33%1.67B-6.59%1.3B-0.81%936.63M14.65%517.22M15.25%1.99B15.53%1.39B23.42%944.29M41.68%451.12M17.50%1.73B
Operating cost -41.52%216.07M-27.23%1.03B-16.26%836.54M-12.52%614.97M12.42%369.5M35.85%1.41B32.94%998.98M43.29%702.99M51.55%328.68M19.20%1.04B
Operating tax surcharges 14.28%6.39M19.31%20.4M16.11%15.08M-3.29%8.82M-7.30%5.59M-6.79%17.1M2.14%12.99M29.64%9.12M141.96%6.03M-8.08%18.35M
Operating expense -11.21%78.39M-6.62%393.86M-8.93%308.74M6.76%217.34M13.64%88.29M-8.99%421.76M4.65%339M5.48%203.58M4.46%77.69M25.97%463.44M
Administration expense 0.20%26.16M6.55%131.76M14.78%93.67M21.71%62.82M9.08%26.11M-3.32%123.66M-2.78%81.61M-6.47%51.61M5.88%23.94M7.46%127.91M
Financial expense -101.84%-131.26K91.38%-6.39M92.35%-6.74M84.38%-8.33M101.43%7.15M-1,429.75%-74.2M-703.53%-88.14M-556.05%-53.33M137.44%3.55M-73.17%5.58M
-Interest expense (Financial expense) -55.98%726.67K13.22%5.93M34.73%5.54M34.62%3.91M-12.51%1.65M215.73%5.23M192.62%4.11M278.29%2.9M408.28%1.89M-80.37%1.66M
-Interest Income (Financial expense) 50.95%-2.02M-100.25%-11.3M-105.66%-8.19M-156.67%-6.18M-428.96%-4.12M-252.63%-5.64M-4.70%-3.98M-17.20%-2.41M35.14%-777.97K73.40%-1.6M
Research and development -15.12%17.48M9.93%97.08M11.20%53.17M35.26%41M83.32%20.59M24.06%88.31M8.59%47.81M10.59%30.31M-2.54%11.23M2.95%71.18M
Credit Impairment Loss -173.91%-6.06M215.42%17.43M250.15%16.64M164.11%8.45M190.02%8.21M-128.80%-15.1M-121.44%-11.08M-1,241.54%-13.19M-166.58%-9.11M113.70%52.43M
Asset Impairment Loss -----3,685.29%-19.62M---1.39K---1.39K---1.39K4.27%-518.22K------0--086.44%-541.35K
Adjustment items of total operating cost -------------------0.01--------------------
Other net revenue -97.67%262.25K17.75%56.13M320.08%28.86M186.84%14.56M254.18%11.24M-23.31%47.67M-124.54%-13.11M-5,077.46%-16.76M-69.42%-7.29M117.18%62.17M
Fair value change income 158.63%430.73K670.53%771.38K122.09%440.84K-10.05%323.9K-63.32%166.55K-89.88%100.11K8.78%198.5K135.87%360.09K599.76%454.06K123.63%988.86K
Invest income 972.47%3.03M270.72%8M143.66%3.65M112.33%945.07K127.73%282.36K-1,244.58%-4.69M-19.26%-8.35M4.60%-7.67M84.45%-1.02M-102.24%-348.72K
Asset deal income -----55.98%25.35M--208.74----------57.59M--------------0
Other revenue 10.95%2.87M135.25%24.2M32.99%8.14M29.65%4.84M8.15%2.59M6.76%10.28M-28.62%6.12M-47.21%3.73M-57.31%2.39M9.77%9.63M
Operating profit 14.45%117.01M-43.24%204.36M-20.18%194.34M-23.40%134.68M8.97%102.23M71.97%360.01M12.35%243.46M62.45%175.83M36.94%93.82M227.06%209.34M
Add:Non operating Income -98.63%1.83K-52.01%350.92K-56.69%25.5M-99.76%141.92K-99.77%133.89K79.92%731.23K14,884.84%58.89M18,480.51%58.58M18,518.53%58.14M749.97%406.43K
Less:Non operating expense 1,636.66%174.4K190.70%1.18M174.83%1.07M-78.49%65.2K-93.47%10.04K10.96%407.28K15.18%388.05K32.25%303.18K20.14%153.74K-91.67%367.03K
Total profit 14.15%116.83M-43.52%203.52M-27.55%218.78M-42.44%134.76M-32.57%102.36M72.10%360.33M39.31%301.96M116.13%234.11M120.99%151.8M223.81%209.38M
Less:Income tax cost -17.64%15.49M-38.52%24.85M-30.47%31.12M-45.03%21.09M-27.69%18.81M75.47%40.42M36.61%44.76M65.62%38.36M82.74%26.01M207.18%23.04M
Net profit 21.30%101.35M-44.15%178.67M-27.04%187.65M-41.93%113.67M-33.58%83.55M71.68%319.91M39.79%257.2M129.87%195.75M130.98%125.8MFLtoP186.34M
Net profit from continuing operation 21.30%101.35M-44.15%178.67M-27.04%187.65M-41.93%113.67M-33.58%83.55M71.68%319.91M39.79%257.2M129.87%195.75M130.98%125.8M226.23%186.34M
Less:Minority Profit -15.20%-2.76M8.99%-3.19M8.91%-10.2M12.35%-5.36M2.22%-2.4M-166.56%-3.5M-88.67%-11.2M-53.03%-6.11M-2,507.97%-2.45M133.73%5.26M
Net profit of parent company owners 21.13%104.11M-43.77%181.86M-26.28%197.86M-41.03%119.03M-32.98%85.95M78.60%323.41M41.32%268.4M126.42%201.86M135.93%128.25M237.16%181.08M
Earning per share
Basic earning per share 23.07%0.0827-44.00%0.14-27.68%0.1549-42.35%0.0931-34.50%0.067266.67%0.2540.74%0.2142125.87%0.1615135.32%0.1026236.36%0.15
Diluted earning per share 23.07%0.0827-44.00%0.14-27.68%0.1549-42.35%0.0931-34.50%0.067266.67%0.2540.74%0.2142125.87%0.1615135.32%0.1026236.36%0.15
Other composite income -2,850.69%-1.32M118.33%420.5K56.43%-1.57M-159.64%-409.7K-106.87%-44.83K-173.72%-2.29M-14,922.82%-3.59M4,878.38%687K2,266.05%652.35K450.79%3.11M
Other composite income of parent company owners -2,850.69%-1.32M118.33%420.5K56.43%-1.57M-159.64%-409.7K-106.87%-44.83K-173.72%-2.29M-14,922.82%-3.59M4,878.38%687K2,266.05%652.35K450.79%3.11M
Total composite income 19.78%100.02M-43.61%179.09M-26.62%186.09M-42.34%113.26M-33.96%83.51M67.65%317.62M37.86%253.61M130.71%196.43M132.06%126.45M227.57%189.46M
Total composite income of parent company owners 19.65%102.79M-43.24%182.28M-25.87%196.29M-41.44%118.62M-33.36%85.9M74.34%321.12M39.45%264.81M127.23%202.54M137.01%128.9M238.59%184.19M
Total composite income of minority owners -15.20%-2.76M8.99%-3.19M8.91%-10.2M12.35%-5.36M2.22%-2.4M-166.56%-3.5M-88.67%-11.2M-53.03%-6.11M-2,507.97%-2.45M133.73%5.26M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Notarized Tianye Certified Public Accountants (Special General Partnership)------Notarized Tianye Certified Public Accountants (Special General Partnership)------Notarized Tianye Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg